DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Companyâs robust platform delivers kidney care services and includes established nephrology and payor relationships. The Companyâs international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Companyâs U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļDVA
āļāļ·āđāļāļāļĢāļīāļĐāļąāļDaVita Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļOct 31, 1995
āļāļĩāļāļĩāđāļRodriguez (Javier J)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ76000
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļOct 31
āļāļĩāđāļāļĒāļđāđ2000 16th St
āđāļĄāļ·āļāļDENVER
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX NASDAQ Basic NYSE
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ80202-5117
āđāļāļĢāļĻāļąāļāļāđ13105362668
āđāļ§āđāļāđāļāļāđhttps://www.davita.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļDVA
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļOct 31, 1995
āļāļĩāļāļĩāđāļRodriguez (Javier J)
Mr. Javier J. Rodriguez
Chief Executive Officer, Director
Chief Executive Officer, Director
Mr. Joel Ackerman
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
Ms. Kathleen Alyce Waters
Ms. Kathleen Alyce Waters
Chief Legal and Public Affairs Officer
Chief Legal and Public Affairs Officer
Ms. Pamela M. Arway
Independent Chair of the Board
Independent Chair of the Board
Mr. Christopher Michael (Chris) Berry
Mr. Christopher Michael (Chris) Berry
Chief Accounting Officer
Mr. James O. Hearty
Chief Compliance Officer
Ms. Barbara J. Desoer
Independent Director
Ms. Phyllis R. Yale
Independent Director
Dr. Gregory J. Moore, M.D., Ph.D.
Dr. Gregory J. Moore, M.D., Ph.D.
Independent Director
Mr. Jason M. Hollar
Independent Director
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Javier J. Rodriguez
Chief Executive Officer, Director
Chief Executive Officer, Director
Mr. Joel Ackerman
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
Ms. Kathleen Alyce Waters
Ms. Kathleen Alyce Waters
Chief Legal and Public Affairs Officer
Chief Legal and Public Affairs Officer
Ms. Pamela M. Arway
Independent Chair of the Board
Independent Chair of the Board
Mr. Christopher Michael (Chris) Berry
Mr. Christopher Michael (Chris) Berry
Chief Accounting Officer
Mr. James O. Hearty
Chief Compliance Officer